Skip to main content

Table 3 Fasting total cholesterol, HDL, LDL and triglyceride plasma concentrations at baseline and 6 months follow-up

From: Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events

 

Baseline

6 months post DMR

p-value

Total cholesterol (mmol/l)

3.64 (3.34–4.89)

3.48 (3.18–3.97)

0.008

HDL (mmol/l)

1.21 (0.95–1.32)

1.15 (1.05–1.47)

0.103

LDL (mmol/l)

1.92 (1.49–2.30)

1.79 (1.49–2.08)

0.044

Triglycerides (mmol/l)

1.79 (1.15–2.66)

1.09 (0.91–1.89)

0.023

  1. Data are expressed as median (Q1-Q3). Paired Wilcoxon signed-rank tests were used to compare measurements between baseline and 6 months
  2. HDL high-density lipoprotein, LDL0 low-density lipoprotein
  3. P-values ≤ 0.05 are displayed in bold
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840